One of the main recommendations is the incorporation of epothilone, a new therapeutic class that starting this month will be available in Mexico
The impact Epothilones have demonstrated in tumors that are resistant to conventional treatment in advanced stages and metastásicasLa Mexican Society of Oncology, AC (SMeO) presented the recommendations of the Expert Panel on Mexican metastatic breast cancer with the aim of presenting an update on the diagnosis and treatment options for patients in Mexico.
The presentation of these recommendations complements the Mexican Consensus Breast Cancer, presented the 2008 SMeO and considers the inclusion of epothilone, a new therapeutic class thus far been absent in our country and whose first product is now available in Mexico through Laboratory Bristol-Myers Squibb.
Media conference, Dr. Cristian Villanueva, Argentine specialist assigned to the University Hospital of Besançon, France, said that “Epothilones have proven effective in tumors resistant to traditional treatments, and a manageable safety profile in cancer patients of locally advanced or metastatic breast cancer who had not previously responded to treatment. ” (more…)
